Circulating miR-421 Targeting Leucocytic Angiotensin Converting Enzyme 2 Is Elevated in Patients with Chronic Kidney Disease
Autor: | Matthias Girndt, Bogusz Trojanowicz, Thomas Imdahl, Roman Fiedler, Christof Ulrich |
---|---|
Rok vydání: | 2018 |
Předmět: |
Male
medicine.medical_specialty 030232 urology & nephrology Peptidyl-Dipeptidase A 030204 cardiovascular system & hematology Proto-Oncogene Mas Cell Line 03 medical and health sciences 0302 clinical medicine Renal Dialysis Internal medicine microRNA Leukocytes medicine Humans In patient Renal Insufficiency Chronic Inverse correlation 3' Untranslated Regions Aged Uremia Aged 80 and over chemistry.chemical_classification business.industry Middle Aged medicine.disease Peptide Fragments Indoxyl sulphate MicroRNAs Enzyme Endocrinology chemistry Specific primers Angiotensin-converting enzyme 2 Female Angiotensin-Converting Enzyme 2 Angiotensin I business hormones hormone substitutes and hormone antagonists Kidney disease |
Zdroj: | Nephron. 141:61-74 |
ISSN: | 2235-3186 1660-8151 |
Popis: | Background: Decreased levels of leucocytic angiotensin converting enzyme 2 (ACE2) relate to atherosclerosis in patients with chronic kidney disease (CKD). Recently, micro RNA 421 (miR-421) was found to target and down-regulate ACE2 in human cardiac myofibroblasts. In this study, we investigated the correlation between serum levels of miR-421 and ACE2 transcripts in circulating leukocytes of healthy individuals (NP), CKD (3–5) and haemodialysis (HD) patients. Furthermore, we tested the possible interaction between miR-421 and 3′-UTR of ACE2 under normal and uremic milieu. Methods: The levels of circulating miR-421, serum Ang1–7 and expression of leucocytic ACE2, ACE, MASR, AT1R and AT2R were investigated in 16 CKD3–5 (76 ± 10 years), 32 HD patients (65 ± 13 years) and 23 NP (51 ± 5 years) by employment of specific primers, TaqMan and competitive enzyme-linked immunosorbent assay assays. Interaction between miR-421 and ACE2–3′-UTR was investigated on THP-1 cells by employment of normal and uremic sera, reporter vectors and miR-421 inhibitor. Effects of uremic toxins indoxyl sulphate, p-cresol and p-cresyl sulphate on ACE2 and miR-421 levels were investigated in THP-1 monocytes. Results: The levels of serum miR-421 were significantly elevated, while Ang1–7 was significantly decreased in CKD3–5 and HD patients as compared with NP. Serum Ang1–7 correlated positively with leucocytic ACE2 (r2 = 0.213, p < 0.001). We found a significant and inverse correlation between the levels of circulating miR-421 and the expression of leucocytic ACE2 (r2 = 0.223, p < 0.0001). Further significant and positive correlations could be demonstrated between miR-421 and the transcripts of leucocytic AT1R (r2 = 0.094, p < 0.05) or eGFR (r2 = 0.231, p < 0.0001) or CRP (r2 = 0.092, p < 0.01). We found no correlations between miR-421 and ACE or AT2R or MASR expression. Treatment with miR-421 or uremic serum led to noticeable decrease of reporter 3′UTR-ACE2. Anti-miR-421 treatment resulted in the up-regulation of ACE2 protein. All uremic toxins tested were able to significantly elevate miR-421 levels and decrease the monocytic ACE2 transcripts. Conclusions: Uremic patients show an enhanced expression of serum miR-421 as compared to healthy individuals. A strong association of circulating miR-421 with decreased transcripts of ACE2 may contribute to the low expression of the enzyme in leukocytes of CKD patients, further supporting the development of atherosclerotic events. |
Databáze: | OpenAIRE |
Externí odkaz: |